Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Post-COVID heart disease fears

Posted 4 May 2020

Specialists are bracing for a potential wave of non-coronavirus illnesses such as cardiovascular disease and other serious conditions as patient numbers at Emergency Departments plummet and pathology tests fall dramatically.

In an article published today (Monday) in the Medical Journal of Australia's InSight+, Australian doctors have relayed their concerns that many conditions are going undiagnosed.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Approvals Action
New registrations for seizures and HIV
Eisai and ViiV add to their core franchises
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas